Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis. | Theranostics | 2022 | 35832075 | PubTator, text mining | PubMed |
| Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer. | Nat Commun | 2022 | 35831322 | PubTator, text mining | PubMed |
| Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors. | J Control Release | 2022 | 35817279 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions. | Front Bioeng Biotechnol | 2022 | 35814023 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology. | Adv Drug Deliv Rev | 2022 | 35809868 | PubTator, text mining | PubMed |
| Dehydrocorydaline Accelerates Cell Proliferation and Extracellular Matrix Synthesis of TNFα-Treated Human Chondrocytes by Targeting Cox2 through JAK1-STAT3 Signaling Pathway. | Int J Mol Sci | 2022 | 35806272 | PubTator, text mining | PubMed |
| Glioblastoma Treatment: State-of-the-Art and Future Perspectives. | Int J Mol Sci | 2022 | 35806212 | PubTator, text mining | PubMed |
| Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives. | Int J Mol Sci | 2022 | 35806051 | PubTator, text mining | PubMed |
| Breast Cancer Genomics: Primary and Most Common Metastases. | Cancers (Basel) | 2022 | 35804819 | PubTator, text mining | PubMed |
| Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma. | Cell Death Dis | 2022 | 35803912 | PubTator, text mining | PubMed |
| Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. | Oncoimmunology | 2022 | 35800158 | PubTator, text mining | PubMed |
| Type-2 Cytokines Promote the Secretion of the Eosinophil-Attractant CCL26 by Intestinal Epithelial Cells in Food-Sensitized Patients. | Front Immunol | 2022 | 35799778 | PubTator, text mining | PubMed |
| A Novel Role of IL13Rα2 in the Pathogenesis of Proliferative Vitreoretinopathy. | Front Med (Lausanne) | 2022 | 35770008 | PubTator, text mining | PubMed |
| Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer. | Aging (Albany NY) | 2022 | 35748788 | PubTator, text mining | PubMed |
| Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13. | Vaccines (Basel) | 2022 | 35746582 | PubTator, text mining | PubMed |
| Hybrid Nanobioengineered Nanomaterial-Based Electrochemical Biosensors. | Molecules | 2022 | 35744967 | PubTator, text mining | PubMed |
| Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells. | Biomolecules | 2022 | 35740975 | PubTator, text mining | PubMed |
| The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis. | Antioxidants (Basel) | 2022 | 35740092 | PubTator, text mining | PubMed |
| Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma. | Neurooncol Adv | 2022 | 35733514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=37